Skip to main content
Supplement ScienceSupplementScience

Types of Zeaxanthin: Forms & Bioavailability

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
Free-form ZeaxanthinHighDirect supplementation — no conversion required
Zeaxanthin from Marigold ExtractHighNatural source — the most common commercial form, often paired with lutein

Free-form Zeaxanthin

Bioavailability: High. Best for: Direct supplementation — no conversion required.

Zeaxanthin from Marigold Extract

Bioavailability: High. Best for: Natural source — the most common commercial form, often paired with lutein.

Full Zeaxanthin Guide

References

  1. RCTAge-Related Eye Disease Study 2 Research Group (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. DOI PubMed
  2. ObservationalBone RA, Landrum JT, Mayne ST, et al. (2001). Macular pigment in donor eyes with and without AMD: a case-control study. Investigative Ophthalmology & Visual Science. PubMed
  3. Meta-analysisChoo YM, Yip KX, Fiander M, Ahmad Kamar A, et al. (2025). Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants.. The Cochrane database of systematic reviews. DOI PubMed
  4. Meta-analysisWilson LM, Tharmarajah S, Jia Y, Semba RD, et al. (2021). The Effect of Lutein/Zeaxanthin Intake on Human Macular Pigment Optical Density: A Systematic Review and Meta-Analysis.. Advances in nutrition (Bethesda, Md.). DOI PubMed
  5. Meta-analysisMa L, Liu R, Du JH, Liu T, et al. (2016). Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.. Nutrients. DOI PubMed
  6. Meta-analysisLiu XH, Yu RB, Liu R, Hao ZX, et al. (2014). Association between lutein and zeaxanthin status and the risk of cataract: a meta-analysis.. Nutrients. DOI PubMed
  7. Meta-analysisMa L, Hao ZX, Liu RR, Yu RB, et al. (2014). A dose-response meta-analysis of dietary lutein and zeaxanthin intake in relation to risk of age-related cataract.. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. DOI PubMed
Show 5 more references
  1. Meta-analysisLiu R, Wang T, Zhang B, Qin L, et al. (2014). Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.. Investigative ophthalmology & visual science. DOI PubMed
  2. Meta-analysisMa L, Dou HL, Wu YQ, Huang YM, et al. (2012). Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.. The British journal of nutrition. DOI PubMed
  3. ObservationalKeenan TDL, Agrón E, Keane PA, Domalpally A, et al. (2025). Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.. Ophthalmology. DOI PubMed
  4. RCTLopresti AL, Smith SJ (2025). The effects of lutein/ zeaxanthin (Lute-gen®) on eye health, eye strain, sleep quality, and attention in high electronic screen users: a randomized, double-blind, placebo-controlled study.. Frontiers in nutrition. DOI PubMed
  5. ReviewMartinez-Perez C, Oliveira AP (2025). Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials.. Nutrients. DOI PubMed